JOY MATTERN: Open Payments
NPI 1790778371 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 34 payments from 10 companies in 2025. Trend: 2023 $531 · 2024 $568 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $156 |
| ABBVIE INC. | 11 | $136 |
| Novo Nordisk Inc | 4 | $66 |
| Lilly USA, LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: PREVNAR 20, VRAYLAR, NURTEC ODT, Ozempic, MOUNJARO, QULIPTA, PAXLOVID, SHINGRIX.
Industry payments across PA — which companies pay providers there.
